Editorial Staff

Alzheimer Breakthrough Disillusionment: Confusion on FDA’s Approval of Expensive and Possibly Ineffective Drug

/in , , , /by Editorial Staff
Share on Facebook
Share on Twitter
Share on
LinkedIn
+

Hubwonk host Joe Selvaggi talks with precision medicine expert Hannah Mamuszka and Pioneer Institute’s Bill Smith about the promises and pitfalls of the newly approved Alzheimer’s drug Aduhelm, and the challenges presented when new, expensive drugs of dubious benefit are introduced to the nation’s formulary.

Guest:

Hannah Mamuszka is Founder & CEO of ALVA10, a healthcare technology firm. Hannah has spent her 20+ year career in diagnostics – both in pharma and at diagnostics companies, in the lab and on the business side. She believes that the challenges of diagnostic technology fully impacting patient care are more commercial than technical, and conceived of ALVA10 to create a mechanism to pull technology into healthcare by aligning incentives through data. She regularly speaks on issues regarding advancement of technology in healthcare, is on the Board of Directors for two diagnostic companies and writes a column on the value of diagnostics for the Journal of Precision Medicine.

Guest Host:

Dr. William S. Smith is Pioneer’s Visiting Fellow in the Life Sciences. Dr. Smith has 25 years of experience in government and in corporate roles. His career includes senior staff positions for the Republican House leadership on Capitol Hill, the White House Office of National Drug Control Policy, and the Massachusetts Governor’s office where he served under Governors Weld and Cellucci. He spent ten years at Pfizer Inc as Vice President of Public Affairs and Policy where he was responsible for Pfizer’s corporate strategies for the U.S. policy environment. He later served as a consultant to major pharmaceutical, biotechnology and medical device companies. Dr. Smith earned his PhD in political science with distinction at The Catholic University of America.

Get new episodes of Hubwonk in your inbox!

Recent episodes:

Small Business Life Support: Policy Relief for Firms Sickened by COVID?

0 Comments
/
Host Joe Selvaggi talks with Pioneer Institute’s Andrew Mikula and Retailers Association of Massachusetts' Jon Hurst about the state of small business in Massachusetts six months into the pandemic.

Supreme Court Vacancy: The History, the Stakes & the Options for Replacing a Justice

0 Comments
/
Hubwonk Host Joe Selvaggi talks with Cato Institute's Ilya Shapiro about his new book, Supreme Disorder: Judicial Nominations and the Politics of America's Highest Court.  The episode equips listeners with historical context to better understand the makeup of the Court, the nomination process, and the impact of a new justice on the Court.

Ranked Choice: Ballot Question 2 Redefines What a Vote and Majority Mean

0 Comments
/
Join host Joe Selvaggi as he discusses Ranked Choice Voting with former Federal Election Commissioner Lee Goodman. As a recognized national expert in election administration, Commissioner Goodman offers a deep dive on the contours of ranked choice voting, including the benefits and challenges moving to the new system would offer Massachusetts voters.

Lockdowns – Lawless or Laudable? Grading Gov. Baker’s COVID-19 Emergency Orders 6 Months On

Join Joe Selvaggi and Pioneer Institute’s executive director Jim Stergios for a conversation with Boston Globe columnist Jeff Jacoby about the lawsuit against the Massachusetts Governor’s executive orders. They will explore what can be learned from the first six months of the COVID-19 pandemic, and what must be considered when devising a new way forward.

Drug Rebates: How Pharmacy Benefit Managers Manipulate Price & Limit Choice

0 Comments
/
Join host Joe Selvaggi and his guest Dr. Bill Smith as they discuss the complex incentive structure between drug manufacturers, health plans, and pharmacy benefit managers. In this episode, they focus on how drug rebates work and how a system intended to optimize value may actually deliver higher costs and fewer choices. Joe and Bill also use this framework to speculate on the price of a COVID-19 vaccine, and who will likely pay for it.

Confronting COVID Constraints: How Certificate of Need laws stifle innovation, increase costs, and reduce quality in healthcare

0 Comments
/
Join Joe Selvaggi and co-host Josh Archambault, Pioneer Institute's Senior Fellow in Healthcare, as they talk with Institute for Justice’s Jaimie Cavanaugh about the effects of Certificate of Need laws on the healthcare system.

The ABCs of the Newest Diagnostic Science for COVID-19 Testing

0 Comments
/
Join Hubwonk host Joe Selvaggi as he talks with Hannah Mamuszka, expert in diagnostic science, about the state of COVID-19 testing technology and its implications for a safer return to school and work in the fall.

Doctors Beyond Borders: Firefly Health Shines a Light on Virtual Primary Care

0 Comments
/
Join Hubwonk host Joe Selvaggi as he speaks with Firefly Health President Fay Rotenberg and Primary Care Doctor and Co-Founder Jeff Greenberg as they discuss the promise and potential of virtual primary care to deliver direct doctor access, price transparency, and more holistic healthcare that may revolutionize the healthcare system.

Non-Profits Facing COVID-19: Charles River’s Esplanade Association on Why It’s No Walk in the Park

0 Comments
/
Join host Joe Selvaggi as he talks with Esplanade Association’s executive director Michael Nichols about how he and other non-profits adapt to a surge in demand for services while coping with a collapse in fundraising opportunities.

Student Loan Collective Bargaining: Leveraging Loan Aggregation for Better Rates

0 Comments
/
Join Hubwonk host Joe Selvaggi as he talks with Chris Abkarians and Nikhil Argawal, co-founders of LeverEdge, about how their new student loan platform uses loan aggregation and competition to secure better rates for student loans.